๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for High-risk Melanoma

Clinical Study on High-fiber Diet and Short-term Fasting in Melanoma Under Immunotherapy With Checkpoint Inhibition NCT07680452NA1 site๐Ÿ“ Berlin Charite University, Berlin, Germany ยท Tests: High-Fiber Diet, High-Fiber Diet and Short-Term Fasting DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition NCT05770102Phase 2, Phase 327 sites๐Ÿ“ Belfast๐Ÿ“ Birmingham๐Ÿ“ Birmingham Cancer Research UK ยท Tests: Atezolizumab A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy NCT06362369Phase 1, Phase 25 sites๐Ÿ“ Aurora๐Ÿ“ Lake Mary๐Ÿ“ Lebanon 7 Hills Pharma, LLC ยท Tests: Alintegimod, Ipilimumab, Nivolumab An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1-positive Patients With Advanced Solid Tumors NCT06942143Phase 11 site๐Ÿ“ Guangzhou Guangzhou FineImmune Biotechnology Co., LTD. ยท Tests: Super1 TCR-T A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors NCT07115043Phase 1, Phase 213 sites๐Ÿ“ Grand Rapids๐Ÿ“ St Louis๐Ÿ“ Pittsburgh AstraZeneca ยท Tests: AZD6750, rilvegostomig Pancreas Registry and High Risk Registry NCT02775461n/a2 sites๐Ÿ“ New York๐Ÿ“ New York Icahn School of Medicine at Mount Sinai Dabrafenib and/or Trametinib Rollover Study NCT03340506Phase 438 sites๐Ÿ“ Scottsdale๐Ÿ“ Bethesda๐Ÿ“ Columbus Novartis Pharmaceuticals ยท Tests: dabrafenib, trametinib A Phase II Clinical Trial on Neo-adjuvant Pembrolizumab in Patients With pT3b-T4a/b cN0M0 Melanoma. NCT07448831Phase 21 site๐Ÿ“ Jette Universitair Ziekenhuis Brussel ยท Tests: Pembrolizumab Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma NCT00040352n/a2 sites๐Ÿ“ Bethesda๐Ÿ“ Bethesda National Cancer Institute (NCI) Adjuvant Tebentafusp in High Risk Ocular Melanoma NCT06246149Phase 315 sites๐Ÿ“ Lake Success๐Ÿ“ Brussels๐Ÿ“ Nice European Organisation for Research and Treatment of Cancer โ€ฆ ยท Tests: Tebentafusp Intradermal Ipilimumab and Nivolumab in High Risk Stage II Melanoma NCT06240143Phase 1, Phase 26 sites๐Ÿ“ Amsterdam๐Ÿ“ Amsterdam๐Ÿ“ Groningen The Netherlands Cancer Institute ยท Tests: Ipilimumab, Nivolumab, Nivolumab Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases NCT04899908Phase 22 sites๐Ÿ“ Boston๐Ÿ“ Boston Brigham and Women's Hospital ยท Tests: Stereotactic Radiation, AGuIX gadolinium-based nanoparticles, Placebo Efficacy and Safety of Neoadjuvant Cadonilimab Plus High-Dose Recombinant Human Interferon ฮฑ1b in Stage III/IV Melanoma. NCT07586904EARLY Phase 11 site๐Ÿ“ Xi'an Xijing Hospital ยท Tests: Cadonilimab and Recombinant Human Interferon ฮฑ1b Combination Therapy High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial NCT06298734NA2 sites๐Ÿ“ Boston๐Ÿ“ Seattle Fred Hutchinson Cancer Center ยท Tests: Exercise Program, Diet Program Camrelizumab Plus Apatinib and Temozolomide as Neoadjuvant in High Risk Acral Melanoma NCT05512481Phase 21 site๐Ÿ“ Beijing Peking University Cancer Hospital & Institute ยท Tests: Camrelizumab Assessment of Short Immunotherapy After Radical Surgery of High-risk Malignant Melanoma NCT06488482Phase 326 sites๐Ÿ“ Helsinki๐Ÿ“ Kuopio๐Ÿ“ Tampere Uppsala University ยท Tests: nivolumab or pembrolizumab Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis NCT06047379Phase 1, Phase 28 sites๐Ÿ“ Beverly Hills๐Ÿ“ Glendale๐Ÿ“ Los Angeles Neonc Technologies, Inc. ยท Tests: NEO212 Oral Capsule, Ipilimumab, Pembrolizumab, Nivolumab, Regorafenib Modified Vaccine for High Risk or Low Residual Melanoma Patients NCT01898039Phase 1, Phase 21 site๐Ÿ“ Jerusalem Hadassah Medical Organization ยท Tests: A2/4-1BBL melanoma vaccine, DNP sensititzation, Cyclophosphamide IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors NCT05039801Phase 11 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Bevacizumab, Glutaminase-1 Inhibitor IACS-6274, Paclitaxel, Capivasertib NY-ESO-1-redirected T Cells in Patients With Advanced Melanoma and Sarcoma NCT06889766Phase 12 sites๐Ÿ“ Lausanne๐Ÿ“ Lausanne Centre Hospitalier Universitaire Vaudois ยท Tests: NY-ESO-1 TCR redirected autologous T cell product, Low-dose irradiation, Non-myeloablative lymphodepleting chemotherapy A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051) NCT02332668Phase 1, Phase 216 sites๐Ÿ“ Aurora๐Ÿ“ Chicago๐Ÿ“ Boston Merck Sharp & Dohme LLC ยท Tests: Pembrolizumab InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer NCT05463796n/a1 site๐Ÿ“ Boston Dana-Farber Cancer Institute ยท Tests: Samples Explorative Study on Addition of High-fiber Dried Chicory Root in Patients With an Intermediate to High-risk Cutaneous Melanoma. NCT07206017NA1 site๐Ÿ“ Groningen University Medical Center Groningen ยท Tests: prebiotic dried chicory root (WholeFiber) Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK) NCT07524114n/a1 site๐Ÿ“ Toronto University Health Network, Toronto Clear Me: Interception Trial to Detect and Clear Molecular Residual Disease in Patients With High-risk Melanoma NCT06319196Phase 21 site๐Ÿ“ Toronto University Health Network, Toronto ยท Tests: Opdualag, Nivolumab Evaluation of a Pragmatic Approach to Adoptive Cell Therapy (ACT) Using an IL2 Analog (ANV419) vs High Dose IL2 After Tumor Infiltrating Lymphocytes (TIL) Therapy in Patients With Melanoma, NSCLC and Cervical Cancer (PragmaTIL) NCT06630611Phase 21 site๐Ÿ“ Barcelona Vall d'Hebron Institute of Oncology ยท Tests: NMA-LD regimen, Tumor infiltrating lymphocytes adoptive cell therapy (TIL-ACT) infusion, High dose IL-2, IL-2 analog Adjuvant Quisinostat in High-Risk Uveal Melanoma NCT06932757Phase 21 site๐Ÿ“ Miami University of Miami ยท Tests: Quisinostat A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors NCT05592626Phase 1, Phase 219 sites๐Ÿ“ Sacramento๐Ÿ“ Celebration๐Ÿ“ Miami Marengo Therapeutics, Inc. ยท Tests: STAR0602, Irinotecan (Camptosar), Docetaxel (Taxotere) Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors NCT07410494Phase 1, Phase 21 site๐Ÿ“ Beijing Essen Biotech ยท Tests: EB-SELECT Single-Target CAR-NK Cells, Dual-Target Antigen-Selected CAR-NK MELAFERT: Impact of Adjuvant Therapy on FERTility in Patients With Resected MELAnoma at High Risk of Relapse. NCT07092670n/a10 sites๐Ÿ“ Bari๐Ÿ“ Genova๐Ÿ“ Milan Intergruppo Melanoma Italiano ยท Tests: Dabrafenib + Trametinib, Pembrolizumab, Nivolumab, Observation
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy